Primary prevention of cardiovascular
Metabolic syndrome in Community Medicine
Crestor Presentation
The ESC/EAS Guidelines
Alto riesgo cardiovascular
Coronary Artery Disease
9#Kuliah CAD Sistem 2011
Anthony N. DeMaria Judith and Jack White Chair in Cardiology Founding Director, Sulpizio Cardiovascular Center UCSD School of Medicine Judith and Jack.
Interactions in Clinical Practice: Drug-Supplement, Drug-Nutrient Leo Galland, M.D. Applied Nutrition, Inc. .
Obesity and Dyslipidemia AR Esteghamati, MD Associate Professor of Internal Medicine Endocrinology and Metabolism Research Center Tehran University of.
Why should cardiologist be concerned about cardio metabolic risk? Prof. D John Betteridge U niversity College London Slide lecture prepared and held by:
Role of Fenofibrate in Diabetic Dyslipidemia. Diabetic Dyslipidaemia Occurs in type 2 diabetes mellitus High levels of triglycerides Low levels of HDL-C.
